SEC Form 4 · accession 0000899243-15-002416
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M. Gravett
Officer — VP, Research & Development
Period of report
Aug 3, 2015
Accepted (ET)
Aug 5, 2015 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.91 | Aug 3, 2015 | A | 47,006 | A | — | Aug 3, 2025 | Common Stock | 47,006 | 47,006 | D |
Explanation of responses
- F1The option shall vest with respect to 1/48 of the underlying shares upon each monthly anniversary of the vesting commencement date of August 1, 2015.